» Articles » PMID: 35446757

Cancer Screening Prevalence and Associated Factors Among US Adults

Overview
Specialty Public Health
Date 2022 Apr 21
PMID 35446757
Authors
Affiliations
Soon will be listed here.
Citing Articles

Breast and cervical cancer screening among women at reproductive age in Cambodia: A secondary analysis of Cambodia Demographic and Health Survey 2022.

Um S, Sopheab H PLoS One. 2025; 20(1):e0295881.

PMID: 39883702 PMC: 11781645. DOI: 10.1371/journal.pone.0295881.


Applying cognitive walkthrough methodology to improve the usability of an equity-focused implementation strategy.

Aschbrenner K, Haines E, Kruse G, Olugbenga A, Thomas A, Khan T Implement Sci Commun. 2024; 5(1):95.

PMID: 39227912 PMC: 11373107. DOI: 10.1186/s43058-024-00630-8.


Cancer health disparities in minority communities: peer support networks can bridge the gap.

Abioye O, Kiel L, Kaufman R, Florez N Cancer Causes Control. 2024; 35(11):1407-1411.

PMID: 39117791 DOI: 10.1007/s10552-024-01903-2.


Harnessing Artificial Intelligence for the Detection and Management of Colorectal Cancer Treatment.

Jacob M, Reddy R, Garcia R, Reddy A, Khemka S, Roghani A Cancer Prev Res (Phila). 2024; 17(11):499-515.

PMID: 39077801 PMC: 11534518. DOI: 10.1158/1940-6207.CAPR-24-0178.


Perspectives on Clinical Adoption Barriers to Blood-Based Multi-Cancer Early Detection Tests across Stakeholders.

Schroll M, Quinn E, Pritchard D, Chang A, Garner Amanti K, Perez O J Pers Med. 2024; 14(6).

PMID: 38929814 PMC: 11204763. DOI: 10.3390/jpm14060593.


References
1.
Aberle D, Adams A, Berg C, Black W, Clapp J, Fagerstrom R . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5):395-409. PMC: 4356534. DOI: 10.1056/NEJMoa1102873. View

2.
Alharbi A, Khan M, Horner R, Brandt H, Chapman C . Impact of Medicaid coverage expansion under the Affordable Care Act on mammography and pap tests utilization among low-income women. PLoS One. 2019; 14(4):e0214886. PMC: 6447234. DOI: 10.1371/journal.pone.0214886. View

3.
Deppen S, Aldrich M, Hartge P, Berg C, Colditz G, Petitti D . Cancer screening: the journey from epidemiology to policy. Ann Epidemiol. 2012; 22(6):439-45. PMC: 4096857. DOI: 10.1016/j.annepidem.2012.03.004. View

4.
Davis M, Renfro S, Pham R, Hassmiller Lich K, Shannon J, Coronado G . Geographic and population-level disparities in colorectal cancer testing: A multilevel analysis of Medicaid and commercial claims data. Prev Med. 2017; 101:44-52. PMC: 6067672. DOI: 10.1016/j.ypmed.2017.05.001. View

5.
Tabar L, Dean P, Chen T, Yen A, Chen S, Fann J . The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer. 2018; 125(4):515-523. PMC: 6588008. DOI: 10.1002/cncr.31840. View